Given that FGFR3 expression is absent in class 2a progressive NMIBC and CIS,3,54 these results further support the hypothesis that the FGFR3-negative rat BiPL model has premalignant molecular features similar to those of progressive NMIBC despite morphological differences. Here, FGFR3 is linked to in situ carcinoma.